Debt-to-equity of Terns Pharmaceuticals, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Terns Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Terns Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 5.1%, a 11% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Terns Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 5.1% +0.51% +11% 30 Sep 2025
Q2 2025 4.5% -0.53% -11% 30 Jun 2025
Q1 2025 4.6% -0.51% -10% 31 Mar 2025
Q4 2024 4.6% -0.53% -10% 31 Dec 2024
Q3 2024 4.6% -0.21% -4.4% 30 Sep 2024
Q2 2024 5% +0.31% +6.6% 30 Jun 2024
Q1 2024 5.1% +0.53% +12% 31 Mar 2024
Q4 2023 5.2% +0.53% +11% 31 Dec 2023
Q3 2023 4.8% -0.34% -6.6% 30 Sep 2023
Q2 2023 4.7% -0.32% -6.4% 30 Jun 2023
Q1 2023 4.5% -0.01% -0.22% 31 Mar 2023
Q4 2022 4.6% +0.17% +3.8% 31 Dec 2022
Q3 2022 5.1% -6% -54% 30 Sep 2022
Q2 2022 5% 30 Jun 2022
Q1 2022 4.6% 31 Mar 2022
Q4 2021 4.5% 31 Dec 2021
Q3 2021 11% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.